Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.

Marlen HaderleinClaudia ScherlSabine SemrauSebastian LettmaierMarkus HechtRamona ErberHeinrich IroRainer FietkauAbbas Agaimy

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2017)

Postoperative radiotherapy is the only significant predictor for LRC. HER2/neu receptor expression is an independent prognostic factor for decreased DFS and DMFS in patients with SDC. In addition to radio(chemo)therapy, intensified first-line treatment regimens should also be evaluated in the future.

Keyphrases

prognostic factors
locally advanced
early stage
patients undergoing
radiation therapy
radiation induced
rectal cancer
photodynamic therapy
squamous cell carcinoma
current status
stem cells
combination therapy
cancer therapy
drug delivery
bone marrow
replacement therapy